Verification of evidence in surgical treatment for colorectal liver metastasis

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 378-380

  Kaido, Toshimi ^a,b  

^a Otsu Municipal Hospital   (Japan)

^b OTSU MUNICIPAL HOSPITAL   (Japan)

Author keywords

Colorectal liver metastasis; Evidence based medicine; Hepatectomy; Randomized controlled trial; Surgical treatment

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; COLORECTAL CANCER; HUMAN; LIVER METASTASIS; LIVER RESECTION; MEDLINE; METHODOLOGY; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION;

COLORECTAL NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; LIVER NEOPLASMS;

EID: 44349107635     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS: Evidence based medicine: What it is and what it isn't. BMJ 1996; 312:71-72.
2. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S: Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg 2005; 9:374-380.
3. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, Malliotakis A, Pedonomou M, Solomou EK, Safioleas M, Alamani M, Grigorakos L, Merikas EM: Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2005; 51:413-418.
4. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242:252-259.
5. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y: Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000; 4:178-184.
6. Kijima M, Togo S, Ichikawa Y, Miura M, Yamagishi S, Matsuo K, Tanaka K, Masui H, Ishikawa T, Ike H, Shimada H: Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases. Anticancer Res 2005; 25:1327-1332.
7. Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, Herfarth C, von Knebel Doeberitz M, Weitz J: Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg 2005; 241:199-205.
8. Zhuang H, Sinha P, Pourdehnad M, Duarte PS, Yamamoto AJ, Alavi A: The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun 2000; 21:793-798.
9. Cervone A, Sardi A, Conaway GL: Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 2000; 66:611-615.
10. Delaunoit T, Alberts SR, Sargent DJ, Green E, Goldberg RM, Krook J, Fuchs C, Ramanathan RK, Williamson SK, Morton RF, Findlay BP: Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 2005; 16:425-429.
11. Fenwick SW, Toogood GJ, Lodge JP, Hull MA: The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 2003; 125:716-729.
12. Rudroff C, Altendorf-Hoffmann A, Stangl R, Scheele J: Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after RO resection of colorectal liver metastases. Langenbecks Arch Surg 1999; 384:243-249.